Profil
Glenn M.
Reicin is Chief Financial Officer at Harmony Biosciences Holdings, Inc. since 2026.
Former roles include Chief Financial Officer & Treasurer at Sigilon Therapeutics, Inc. from 2019 to 2021; President at Greyrock Biomedical Advisors Ltd. from 2013 to 2019; Director at SpinalMotion, Inc. from 2009 to 2014; Director at Novasys Medical, Inc. from 2009 to 2013; Managing Director at Skyline Management LLC from 2009 to 2012; Director at SI-BONE, Inc. from 2010 to 2012; Managing Director at Morgan Stanley & Co. LLC from 1993 to 2008; Independent Director at Amplitude Healthcare Acquisition Corp.; Analyst at Fidelity Management & Research Co. LLC; Senior Vice President at Oppenheimer & Co., Inc.; Management Consultant at Bain & Co., Inc.; and Chief Financial & Operating Officer at Alladapt Immunotherapeutics, Inc. Education includes undergraduate studies at Brandeis University and an MBA from Harvard Business School.
Postes actifs de Glenn M. Reicin
| Sociétés | Poste | Début |
|---|---|---|
| HARMONY BIOSCIENCES HOLDINGS, INC. | Directeur Financier/CFO | 14/04/2026 |
Anciens postes connus de Glenn M. Reicin
| Sociétés | Poste | Fin |
|---|---|---|
| SIGILON THERAPEUTICS, INC. | Directeur Financier/CFO | 14/06/2021 |
Greyrock Biomedical Advisors Ltd.
Greyrock Biomedical Advisors Ltd. Investment ManagersFinance Provides financial advisory services | President | 01/05/2019 |
SpinalMotion, Inc.
SpinalMotion, Inc. Medical SpecialtiesHealth Technology Designs, develops, and markets cervical artificial discs for use in the spine | Directeur/Membre du Conseil | 01/01/2014 |
Novasys Medical, Inc.
Novasys Medical, Inc. Medical/Nursing ServicesHealth Services Develops therapies for women's health | Directeur/Membre du Conseil | 01/01/2013 |
Skyline Management LLC
Skyline Management LLC Investment ManagersFinance Skyline Management invests in companies located in the United States. The firm focuses on companies operating in the fields of healthcare market, including biotechnology, therapeutics, medical devices, consumables and equipment for life sciences research and healthcare information technology. It participates in financing for early stage and later stage transactions with an investment size between USD 15 and 25 million. | Private Equity Investor | 01/01/2012 |
Formation de Glenn M. Reicin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Fidelity Management & Research Co. LLC
Fidelity Management & Research Co. LLC Investment ManagersFinance FMR invests in securities of companies engaged in a variety of economic sectors and industries that are domiciled in the US and outside the US (in developed, emerging and frontier markets); in stocks with growth or value characteristics; and in companies with market capitalizations of all sizes. The firm invests across different asset classes, market sectors, maturities, and regions. | Finance |
Oppenheimer & Co., Inc.
Oppenheimer & Co., Inc. Investment ManagersFinance Provides wealth and asset management, brokerage & investment banking services | Finance |
Novasys Medical, Inc.
Novasys Medical, Inc. Medical/Nursing ServicesHealth Services Develops therapies for women's health | Health Services |
SpinalMotion, Inc.
SpinalMotion, Inc. Medical SpecialtiesHealth Technology Designs, develops, and markets cervical artificial discs for use in the spine | Health Technology |
SI-BONE, Inc.
SI-BONE, Inc. Medical SpecialtiesHealth Technology Operates as a sacroiliac joint medical device company | Health Technology |
Morgan Stanley & Co. LLC
Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Bain & Co., Inc.
Bain & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Provides strategy, marketing, organization, operations, IT and M&A consulting services | Commercial Services |
Skyline Management LLC
Skyline Management LLC Investment ManagersFinance Skyline Management invests in companies located in the United States. The firm focuses on companies operating in the fields of healthcare market, including biotechnology, therapeutics, medical devices, consumables and equipment for life sciences research and healthcare information technology. It participates in financing for early stage and later stage transactions with an investment size between USD 15 and 25 million. | Finance |
Brandeis University
Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sigilon Therapeutics, Inc.
Sigilon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics and functional cures for patients with chronic diseases | Health Technology |
Harmony Biosciences Holdings, Inc.
Harmony Biosciences Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for patients living with rare neurological disorders | Health Technology |
Greyrock Biomedical Advisors Ltd.
Greyrock Biomedical Advisors Ltd. Investment ManagersFinance Provides financial advisory services | Finance |
Amplitude Healthcare Acquisition Corp.
Amplitude Healthcare Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Alladapt Immunotherapeutics, Inc.
Alladapt Immunotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics targeting food allergy | Health Technology |
















